EGFR and non-small cell lung carcinoma: While prior studies have linked CD73 expression to EGFR‐driven signaling and poor prognosis in cancer patients,[44, 45, 46] our findings delineate the precise molecular mechanism underlying CD73 upregulation in EGFR‐mutant NSCLC and confirming its pivotal role in shaping an immunosuppressive TME.